批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/01/31 |
SUPPL-25(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2018/02/01 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/07/31 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/04/27 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/02/03 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2014/03/11 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/03/06 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/01/31 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/01/31 |
SUPPL-12(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2012/08/30 |
SUPPL-8(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2010/11/19 |
SUPPL-7(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/05/07 |
SUPPL-6(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2009/02/17 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/12/18 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/07/27 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/07/19 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/11/03 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/06/03 |
ORIG-1(原始申请) |
Approval |
Type 5 - New Formulation or New Manufacturer |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
001 |
5250534 |
2012/03/27 |
Y |
Y |
|
|
|
PDF格式 | **本条是由Drugfuture回溯的历史信息** |
与本品治疗等效的药品
活性成分:SILDENAFIL CITRATE 剂型/给药途径:TABLET;ORAL 规格:EQ 20MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021845 |
001 |
NDA |
REVATIO |
SILDENAFIL CITRATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
Yes |
Yes |
AB |
2005/06/03
|
VIATRIS |
091479 |
001 |
ANDA |
SILDENAFIL CITRATE |
SILDENAFIL CITRATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2012/11/06
|
TORRENT PHARMS LTD |
202503 |
001 |
ANDA |
SILDENAFIL CITRATE |
SILDENAFIL CITRATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2012/11/06
|
WATSON LABS INC |
202598 |
001 |
ANDA |
SILDENAFIL CITRATE |
SILDENAFIL CITRATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2012/11/06
|
CHARTWELL RX |
201150 |
001 |
ANDA |
SILDENAFIL CITRATE |
SILDENAFIL CITRATE |
TABLET;ORAL |
EQ 20MG BASE |
Discontinued |
No |
No |
AB |
2012/11/09
|
MYLAN PHARMS INC |
078380 |
001 |
ANDA |
SILDENAFIL CITRATE |
SILDENAFIL CITRATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2013/01/07
|
TEVA PHARMS |
202025 |
001 |
ANDA |
SILDENAFIL CITRATE |
SILDENAFIL CITRATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2013/02/28
|
AMNEAL PHARMS |
203814 |
001 |
ANDA |
SILDENAFIL CITRATE |
SILDENAFIL CITRATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2013/12/17
|
MACLEODS PHARMS LTD |
203623 |
001 |
ANDA |
SILDENAFIL CITRATE |
SILDENAFIL CITRATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2014/11/26
|
HETERO LABS LTD V |
203963 |
001 |
ANDA |
SILDENAFIL CITRATE |
SILDENAFIL CITRATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2015/11/18
|
AUROBINDO PHARMA LTD |
204883 |
001 |
ANDA |
SILDENAFIL CITRATE |
SILDENAFIL CITRATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2016/06/20
|
RUBICON |
210394 |
001 |
ANDA |
SILDENAFIL CITRATE |
SILDENAFIL CITRATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2018/05/04
|
AJANTA PHARMA LTD |